Physician profile
George Chow
NPI 1932122413
$16,248.28
in general payments reported to CMS, 2019-2025
75 companies · $1,960 in 2025
The $1,960 reported for 2025 was more than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,792 · 2020: $2,062 · 2021: $2,665 · 2022: $3,013 · 2023: $2,327 · 2024: $2,430 · 2025: $1,960.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,673 · Education: $42.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,673.46 |
| Education | $42.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,919.04 | 2019-2025 | Qulipta, Ubrelvy, Botox |
| Novartis Pharmaceuticals Corporation | $1,269.37 | 2019-2025 | |
| Biogen, INC. | $981.37 | 2019-2025 | Vumerity, Leqembi |
| Teva Pharmaceuticals USA, INC. | $932.16 | 2019-2025 | Austedo Xr, Austedo Xr, Ajovy |
| Sk Life Science, INC. | $682.00 | 2020-2025 | Xcopri |
| Amgen INC. | $638.88 | 2019-2025 | Uplizna |
| Ucb, INC. | $614.30 | 2019-2025 | Briviact |
| Acadia Pharmaceuticals INC | $529.56 | 2019-2025 | Nuplazid |
| Kyowa Kirin, INC. | $487.77 | 2019-2024 | Nourianz |
| Eisai INC. | $417.19 | 2019-2025 | |
| Pfizer INC. | $392.51 | 2023-2025 | |
| Otsuka America Pharmaceutical, INC. | $366.39 | 2023-2025 | Rexulti, Nuedexta |
| Mdd US Operations, LLC | $355.20 | 2019-2025 | Gocovri, Apokyn |
| Sunovion Pharmaceuticals INC. | $327.99 | 2020-2022 | |
| Lilly USA, LLC | $294.48 | 2019-2025 | Kisunla, Emgality, Amyvid |
Show all 75 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw George Chow listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.